Prevision Medicine joins the Genolier Innovation Network

Prevision Medicine is proud to announce its membership in the Genolier Innovation Network, a cross-disciplinary ecosystem designed to break down silos and accelerate disruptive health innovations.

This partnership represents an exciting milestone in our mission to advance functional precision medicine and drive meaningful impact in patient care.

As part of the network, we look forward to sharing our expertise, showcasing our innovations, and collaborating on transformative projects that will help shape the future of precision oncology—ultimately delivering more personalized and effective treatments for patients.

Our immediate focus will be on working closely with Prof. Lana E. Kandalaft, Chief of Clinical and Translational Research at Swiss Medical Network, and engaging with the network’s community of oncologists to explore new avenues for translational research and clinical collaboration.

Together, we are putting the future of functional precision medicine in motion—today.